Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?

Registros relacionados

• Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
  por: Tomlinson, J, et al.
  Publicado em: (2001)
• Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
  por: Stewart, P, et al.
  Publicado em: (2002)
• The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
  por: Tomlinson, J, et al.
  Publicado em: (2002)
• The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
  por: Tomlinson, J, et al.
  Publicado em: (2000)
• Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.
  por: Tomlinson, J, et al.
  Publicado em: (2005)